English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody

MPS-Authors
/persons/resource/persons147313

Theurich,  Sebastian
Neuronal Control of Metabolism, Department Jens Brüning, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Chakupurakal, G., Garcia-Marquez, M. A., Shimabukuro-Vornhagen, A., Theurich, S., Holtick, S., Hallek, M., et al. (2016). Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody. European Journal of Haematology, 97(2), 121-127. doi:10.1111/ejh.12691.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0029-20B9-E
Abstract
There is no abstract available